المؤلفون: Samuel Ebele Udeabor

المصدر: Trends in Pharmaceutical Biotechnology, Vol 2, Iss 2 (2024)

مصطلحات موضوعية: Monoclonal antibodies, therapeutic interventions, personalized medicine, immunogenicity, biomedical innovation, Biotechnology, TP248.13-248.65, Pharmaceutical industry, HD9665-9675

وصف الملف: electronic resource

Relation: https://tpb.nabea.pub/tpb/article/view/17; https://doaj.org/toc/3005-7736; https://doaj.org/toc/3005-7744

URL الوصول: https://doaj.org/article/2b7addfd19904c59ad8c1a3781bee667

المؤلفون: Solyman Hatami, MD, Vamsi Maturi, MD, Alwin Mathew, MD, Shannon Lu, MD, Paul Haddad, MD, Daanish Sheikh, BS, Maham Rahimi, MD, PhD

المصدر: Journal of Vascular Surgery Cases and Innovative Techniques, Vol 10, Iss 6, Pp 101599- (2024)

مصطلحات موضوعية: EVAR explantation, Open endograft explantation, Biomedical innovation, Abdominal aortic aneurysm, Aortic graft infection, Surgery, RD1-811, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2468428724001837; https://doaj.org/toc/2468-4287

URL الوصول: https://doaj.org/article/c51bc7061de84684a5a1f5efc5c97f68

المؤلفون: Aust, Jokubas Felix

المساهمون: Arantes-Oliveira, Nuno, RUN

مصطلحات موضوعية: Arachidonic acid, Micro encapsulation, Vascular surgery, Biotechnology, Biomedical innovation, Venture development, Molecular medicine, Pharmaceutical sciences, Hemostatic agents, Pharmacokinetics, Intellectual property, Market access, Business strategy, Domínio/Área Científica::Ciências Sociais::Economia e Gestão

وصف الملف: application/pdf

الاتاحة: http://hdl.handle.net/10362/176203

المؤلفون: Dalichau, Mos Frederik

المساهمون: Arantes-Oliveira, Nuno, RUN

مصطلحات موضوعية: Micro encapsulation, Vascular surgery, Biotechnology, Biomedical innovation, Venture development, Molecular medicine, Pharmaceutical sciences, Hemostatic agents, Market access, Business strategy, Competitive analysis, Healthcare economics, Regulatory strategy, Domínio/Área Científica::Ciências Sociais::Economia e Gestão

وصف الملف: application/pdf

الاتاحة: http://hdl.handle.net/10362/176198

المؤلفون: Marr, Jonas Maximilian Augustinus

المساهمون: Arantes-Oliveira, Nuno, RUN

مصطلحات موضوعية: Arachidonic acid, Micro encapsulation, Vascular surgery, Biotechnology, Biomedical innovation, Molecular medicine, Pharmaceutical sciences, Hermostatic agents, Pharmacokinetics, Intellectual property, Market access, Business strategy, Domínio/Área Científica::Ciências Sociais::Economia e Gestão

وصف الملف: application/pdf

الاتاحة: http://hdl.handle.net/10362/174502

المؤلفون: Hu, Wanheng¹ (AUTHOR)

المصدر: Journal of Development Studies. Jun2023, Vol. 59 Issue 6, p955-957. 3p.

مصطلحات موضوعية: *BUSINESSPEOPLE, *ENTREPRENEURSHIP, *BUSINESS incubators, *FOREIGN investments, *INDUSTRIAL districts, MEDICAL innovations, ENTREPRENEURSHIP education

Reviews & Products: BEYOND Technonationalism: Biomedical Innovation & Entrepreneurship in Asia (Book)

المؤلفون: Joseph L. Mathew, T. Lazar Mathew

المصدر: Annals of the National Academy of Medical Sciences (India), Vol 56, Iss 02, Pp 077-086 (2020)

مصطلحات موضوعية: biomedical innovation, covid-19, respiratory support, artificial breathing capability device, innovation pathway, innovation ecosystem, General works, R5-130.5, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/0379-038X; https://doaj.org/toc/2454-5635

URL الوصول: https://doaj.org/article/18d741f414b34c2c93e11bdd3eb2fcf6

المؤلفون: Benjamin J. Anderson, Olena Leonchuk, Alan C. O’Connor, Brooke K. Shaw, Amanda C. Walsh

المصدر: Journal of Clinical and Translational Science, Vol 6 (2022)

مصطلحات موضوعية: Academic entrepreneurship, biomedical innovation, proof-of-concept, accelerator, evaluation, commercialization, technology development, SBIR/STTR, Medicine

وصف الملف: electronic resource

Relation: https://www.cambridge.org/core/product/identifier/S2059866121008785/type/journal_article; https://doaj.org/toc/2059-8661

URL الوصول: https://doaj.org/article/3bc6fc3112094666a37697afdccb26a1

المساهمون: Halabi, Sam F., editor, Gostin, Lawrence O., editor, Crowley, Jeffrey S., editor

الاتاحة: https://doi.org/10.1093/acprof:oso/9780190604882.001.0001

المؤلفون: Georgia Miller, Declan Kuch, Matthew Kearnes

المصدر: Minerva

مصطلحات موضوعية: Research policy, Politics, Neoliberalism, Australia, General Social Sciences, Biomedical innovation, Health bioeconomy, Article, Health policy, Social Sciences (miscellaneous), Education

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb44b0b5e26e44783834f56ded6bf80f
https://doi.org/10.1007/s11024-021-09456-3

المؤلفون: Boenink, Marianne, van der Scheer, Lieke, Garcia, Elisa, van der Burg, Simone

المصدر: NanoEthics 12 (2018) 3 ; ISSN: 1871-4757

مصطلحات موضوعية: Biomedical innovation, Discussion method, Experiential knowledge, Patient involvement, Research and development, Translational research

وصف الملف: application/pdf

Relation: https://edepot.wur.nl/455723

الاتاحة: https://research.wur.nl/en/publications/giving-voice-to-patients-developing-a-discussion-method-to-involv
https://doi.org/10.1007/s11569-018-0319-8

المؤلفون: Yi, Doogab¹ doogab@snu.ac.kr

المصدر: Journal of Asian Studies. May2020, Vol. 79 Issue 2, p556-558. 3p.

مصطلحات موضوعية: *BIOTECHNOLOGY, *ENTREPRENEURSHIP, *NONFICTION

Reviews & Products: BEYOND Technonationalism: Biomedical Innovation & Entrepreneurship in Asia (Book)

People: IBATA-Arens, Kathryn

المؤلفون: Price, W. Nicholson, II

المصدر: Reviews

مصطلحات موضوعية: article review, biomedical innovation policy, Orphan Drug Act, Hatch-Waxman Act, Drug Price Competition and Patent Term Restoration Act of 1984, Affordable Care Act (ACA), Medicare Part D, Food and Drug Law, Health Law and Policy, Science and Technology Law

وصف الملف: application/pdf

Relation: https://repository.law.umich.edu/reviews/197; https://repository.law.umich.edu/cgi/viewcontent.cgi?article=1197&context=reviews

الاتاحة: https://repository.law.umich.edu/reviews/197
https://repository.law.umich.edu/cgi/viewcontent.cgi?article=1197&context=reviews

المؤلفون: Elnathan, Roey, Barbato, Maria Grazia, Guo, Xiangfu, Mariano, Anna, Wang, Zixun, Santoro, Francesca, Shi, Peng, Voelcker, Nicolas H., Xie, Xi, Young, Jennifer L., Zhao, Yunlong, Zhao, Wenting, Chiappini, Ciro

المساهمون: School of Chemical and Biomedical Engineering

مصطلحات موضوعية: Engineering::Bioengineering, Biointerfaces, Biomedical Innovation

Relation: RG112/20; NGF-2021-10-026; MOET32020-0001; NRF2019-NRFISF003-3292; Nature Reviews Materials; Elnathan, R., Barbato, M. G., Guo, X., Mariano, A., Wang, Z., Santoro, F., Shi, P., Voelcker, N. H., Xie, X., Young, J. L., Zhao, Y., Zhao, W. & Chiappini, C. (2022). Biointerface design for vertical nanoprobes. Nature Reviews Materials, 7(12), 953-973. https://dx.doi.org/10.1038/s41578-022-00464-7; https://hdl.handle.net/10356/163461; 2-s2.0-85135831895; 12; 953; 973

الاتاحة: https://hdl.handle.net/10356/163461
https://doi.org/10.1038/s41578-022-00464-7

المؤلفون: Kim, Young-Hwa, Gautam, Ajay

المصدر: Journal of Medicines Development Sciences; Vol 1. No. 1 (Published); 3-9 ; 2382-6371 ; 2382-6363

مصطلحات موضوعية: biomedical innovation, capital investments, operating models, Asia, in-licensing, joint ventures, research collaborations, open innovation

وصف الملف: application/pdf

Relation: https://ojs.whioce.com/index.php/jmds/article/view/108/93; https://ojs.whioce.com/index.php/jmds/article/view/108

الاتاحة: https://ojs.whioce.com/index.php/jmds/article/view/108
https://doi.org/10.18063/jmds.v1i1.108

المؤلفون: Eugene Shlyakhto V., Евгений Шляхто Владимирович

المصدر: Translational Medicine; № 1 (2014); 5-18 ; Трансляционная медицина; № 1 (2014); 5-18 ; 2410-5155 ; 2311-4495 ; 10.18705/2311-4495-2014-0-1

مصطلحات موضوعية: трансляционная медицина, трансляционные исследования, трансляционные барьеры, доклинические исследования, разработка лекарственных препаратов, лечебные и диагностические технологии, биомедицинские инновации, translational medicine, translational research, translational barriers, preclinical studies, drug development, therapeutic and diagnostic techniques, biomedical innovation

وصف الملف: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/3/4; DiMasi J.A., Grabowski H.G. Economics of new oncology drug development // J. Clin. Oncol. - 2007. - Vol. 25, № 2. - P. 209-216.; Contopoulos-Ioannidis D.G., Ntzani E., Ioannidis J.P. Translation of highly promising basic science research into clinical applications // Am. J. Med. - 2003. - Vol. 114, № 6. - P. 477-484.; Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates? // Nat. Rev. Drug Discov. - 2004. - Vol. 3, № 8. - P. 711-715.; Marincola F.M. Translational medicine: A two-way road // J. Transl. Med. - 2003. - Vol. 1, № 1. - P. 1.; Zerhouni E.A. Translational and clinical science-time for a new vision // N. Engl. J. Med. -2005. - Vol. 353, № 15. - P. 1621-1623.; Choi D.W. Bench to bedside: the glutamate connection // Science. - 1992. - Vol. 258, № 5080. - P. 241-243.; Editor. Phagocytes and the «bench-bedside interface» // N. Eng. J. Med. - 1968. - Vol. 278. - P. 1014-1016.; Rubio D.M., Schoenbaum E.E., Lee L.S. et al. Defining translational research: Implications for training // Academic Med. - 2010. - Vol. 85. - P. 470-475.; Brander C., Ferrone S., Marincola F.M. Rewarding patient-directed research: Excellence in Translational Medicine Award // J. Transl. Med. - 2006. - Vol. 4. - P. 19.; Интернет-ресурс, URL: http://www.gloucestershire.police.uk/counterterrorism/CTSAs%20Advice/item3983.html; Woolf S.H. The meaning of translational research and why it matters // JAMA: The Journal of the American Medical Association. - 2008. - Vol. 299. - P. 211-213.; Sung N.S., Crowley W.F.J., Genel M., Salber P., Sandy L., Sherwood L.M., et al. Central challenges facing the national clinical research enterprise // JAMA. - 2003. - Vol. 289, № 10. - P. 1278-1287.; Westfall J.M., Mold J., Fagnan L. Practice-based research - «Blue Highways» on the NIH roadmap // JAMA. - 2007. - Vol. 297, № 4. - P. 403-406.; Tageja N. Bridging the translation gap - new hopes, new challenges // Fundam. Clin. Pharmacol. - 2011. - Vol. 25, № 2. - P. 163-171.; Morris Z.S., Wooding S., Grant J. The answer is 17 years, what is the question: understanding time lags in translational research // J.R. Soc. Med. - 2011. - Vol. 104, № 12. - P. 510-520.; Decullier E., Lheritier V., Chapuis F. Fate of biomedical research protocols and publication bias in France: retrospective cohort study // BMJ. - 2005. - Vol. 331. - P. 19.; Grant J., Cottrel L.R., Cluzeau F., Fawcett G. Evaluating «payback» on biomedical research from papers cited in clinical guidelines: applied bibliometric study // BMJ. - 2000. - Vol. 320. - P. 1107-1111.; Sternitzke C. Knowledge sources, patent protection, and commercialization of pharmaceutical innovations // Res. Policy. - 2010. - Vol. 39. - P. 810-821.; Ioannidis J. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials // JAMA. - 1998. - Vol. 279. - P. 281.; Wratschko K. Empirical Setting: The pharmaceutical industry. Strategic Orientation and Alliance Portfolio Configuration. New York, NY: Springer, 2009.; Balas E., Boren S. Managing clinical knowledge for health care improvement / van Bemmel J.H., McCray A.T. eds. Yearbook of Medical Informatics. - Stuttgart: Schattauer Verlagsgesellschaft mbH, 2000. - P. 65-70.; Trochim W., Kane C., Graham M.J., Pincus H.A. Evaluating translational research: a process marker model // Clin. Transl. Sci. - 2011. - Vol. 4, № 3. - P. 153-162.; Prabhakar S. Translational research challenges: finding the right animal models // J. Investig. Med. - 2012. - Vol. 60, № 8. - P. 1141-1146.; Storer R.D., Sistare F.D., Reddy M.V., DeGeorge J.J. An industry perspective on the utility of short-term carcinogenicity testing in transgenic mice in pharmaceutical development // Toxicol. Pathol. - 2010. - Vol. 38, № 1. - P. 51-61.; Galagudza M., Blokhin I.O., Shmonin A.A., Mischenko K.A. Reduction of myocardial ischemia-reperfusion injury with pre- and postconditioning: molecular mechanisms and therapeutic targets // Cardiovasc. Hematol. Disord. Drug Targ. - 2008. - Vol. 8, № 1. - P. 47-65.; Шляхто Е.В., Нифонтов Е.М., Галагудза М.М. Пре- и посткондиционирование как способы кардиоцитопротекции: патофизиологические и клинические аспекты // Сердечная недостаточность. - 2008. - Т. 9, № 1. - С. 4-10.; Miura T., Miki T. Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy // Basic Res. Cardiol. - 2008. - V. 103, № 6. - P. 501-513.; Ludman A.J., Yellon D.M., Hausenloy D.J. Cardiac preconditioning for ischaemia: lost in translation // Dis. Model. Mech. - 2010. - Vol. 3, № 1-2. - P. 35-38.; Cohen M.V., Downey J.M. Is it time to translate ischemic preconditioning’s mechanism of cardioprotection into clinical practice? // J. Cardiovasc. Pharmacol. Ther. - 2011. - Vol. 16, № 3-4. - P. 273-280.; Lefer D.J., Bolli R. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation // J. Cardiovasc. Pharmacol. Ther. - 2011. - Vol. 16, № 3. - P. 332-339.; Pitarys C.J., Virmani R., Vildibill H.D. et al. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period // Circulation. - 1991. - Vol. 83, № 1. - P. 237-247.; Velasco C.E., Turner M., Cobb M.A. et al. Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: effect of intracoronary adenosine // Am. Heart J. - 1991. - Vol. 122, № 6. - P. 1561-1570.; Norton E. D., Jackson E. K., Turner M. B. et al. The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury // Am. Heart J. - 1992. - Vol. 123, № 2. - P. 332-338.; Vander Heide R.S., Reimer K.A. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs // Cardiovasc. Res. - 1996. - Vol. 31, № 5. - P. 711-718.; Goto M., Miura T., Iliodoromitis E.K. et al. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species // Cardiovasc. Res. -1991. - Vol. 25, № 11. - P. 943-949.; Budde J.M., Velez D.A., Zhao Z.Q. et al. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury duringh of reperfusion // Cardiovasc. Res. - 2000. - Vol. 47, № 2. - P. 294-305.; Mahaffey K.W., Puma J.A., Barbagelata N.A. et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial // J. Am. Coll. Cardiol. - 1999. - Vol. 34, № 6. - P. 1711-1720.; Ross A.M., Gibbons R.J., Stone G.W. et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) // J. Am. Coll. Cardiol. - 2005. - Vol. 45, № 11. - P. 1775-1780.; Piot C., Croisille P., Staat P. et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction // N. Engl. J. Med. - 2008. - Vol. 359, № 5. - P. 473-481.; Hausenloy D.J., Baxter G., Bell R. et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations // Basic Res. Cardiol. - 2010. - Vol. 105, № 6. - P. 677-686.; Шляхто Е.В., Баранцевич Е.Р., Щербак Н.С., Галагудза М.М. Молекулярные механизмы формирования ишемической толерантности головного мозга. Часть 1 // Вестник Российской академии медицинских наук. - 2012. - № 6. - С. 42-50.; Шляхто Е.В., Баранцевич Е.Р., Щербак Н.С., Галагудза М.М. Молекулярные механизмы формирования ишемической толерантности головного мозга. Часть 2 // Вестник Российской академии медицинских наук. - 2012. - № 7. - С. 20-29.; Recommendations for standards regarding preclinical neuroprotective and restorative drug development // Stroke. - 1999. - Vol. 30. - P. 2752-2758.; Fisher M., Feuerstein G., Howells D.W. et al. STAIR Group. Update of the stroke therapy academic industry roundtable preclinical recommendations // Stroke. - 2009. - Vol. 40. - P. 2244-2250.; O’Collins V.E., Macleod M.R., Donnan G.A., Horky L.L., van der Worp B.H., Howells D.W. 1,026 experimental treatments in acute stroke // Ann. Neurol. - 2006. - Vol. 59. - P. 467-477.; Lapchak P.A., Zhang J.H., Noble-Haeusslein L.J. RIGOR guidelines: escalating STAIR and STEPS for effective translational research // Transl. Stroke Res. - 2013. - Vol. 4, № 3. - P. 279-285.; Schneider G. Virtual screening: An endless staircase? // Nat. Rev. Drug Discov. - 2010. - Vol. 9. - P. 273-276.; Inoue H., Yamanaka S., The use of induced pluripotent stem cells in drug development // Clin. Pharmacol. Ther. - 2011. - Vol. 89. - P. 655.; Wehling M. Drug development in the light of translational science: shine or shade? // Drug Discov. Today. - 2011. - Vol. 16. № 23-24. - P. 1076-1083.; Nicholls S.J., Tuzcu E.M., Brennan D.M., Tardif J.C., Nissen S.E. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation) // Circulation. - 2008. - Vol. 118, № 24. - P. 2506-2514.; https://transmed.almazovcentre.ru/jour/article/view/3

الاتاحة: https://transmed.almazovcentre.ru/jour/article/view/3
https://doi.org/10.18705/2311-4495-2014-0-1-13-22

المؤلفون: Saskia N. de Wildt, Arjan de Vries, Wouter H. J. Vaes, Bianca D van Groen, Dick Tibboel, Esther van Duijn, M. G. Mooij

المساهمون: Pediatric Surgery

المصدر: Clinical Pharmacology and Therapeutics, 108, 5, pp. 1003-1009
Clinical Pharmacology and Therapeutics, 108, 1003-1009
Clinical Pharmacology and Therapeutics, Epub 9 May
Clinical Pharmacology and Therapeutics, 108(5), 1003-1009. Wiley-Blackwell

مصطلحات موضوعية: Metabolite, Biomedical Innovation, Urine, Pharmacology, 030226 pharmacology & pharmacy, law.invention, Excretion, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, law, medicine, Pharmacology (medical), Dosing, ADME, Clinical pharmacology, business.industry, Area under the curve, chemistry, 030220 oncology & carcinogenesis, Midazolam, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], business, Healthy Living, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48212d9cb583aee4662b8373a40c9ecb
https://doi.org/10.1002/cpt.1884

المؤلفون: Salter, Brian, Zhou, Yinhua, Datta Burton, Saheli

المصدر: Salter , B , Zhou , Y & Datta Burton , S 2015 , ' Hegemony in the marketplace of biomedical innovation : Consumer demand and stem cell science ' , Social Science & Medicine , vol. 131 , pp. 156–163 . https://doi.org/10.1016/j.socscimed.2015.03.015

مصطلحات موضوعية: Health consumers, Market, Hegemony, Political economy, Biomedical innovation, Stem cells, Governance, Bioethics

وصف الملف: application/pdf

الاتاحة: https://kclpure.kcl.ac.uk/portal/en/publications/c16c16e3-96bf-4865-a594-608df2bf4c31
https://doi.org/10.1016/j.socscimed.2015.03.015
https://kclpure.kcl.ac.uk/ws/files/35026614/Hegemony_and_biomedical_innovation_SSM.pdf

المؤلفون: Roberts, Edward B., Hauptman, Oscar

المصدر: Management Science, 1987 Mar 01. 33(3), 381-394.

URL الوصول: https://www.jstor.org/stable/2631858

المؤلفون: Sigurdson, Krista Mary Smith

مصطلحات موضوعية: Sociology, Gender studies, biomedical innovation, breastfeeding, breast milk, human milk banking, human milk sharing, tissue exchange

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/319639p1